SCHEMBL6508623

SCHEMBL6508623

COc1ccc(C(C=O)c2ccccn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.48
KDM4E B2RXH2 4/20 0.47
TSHR P16473 2/20 0.47
SLC6A3 Q01959 2/20 0.47
ABCB11 O95342 1/20 0.47
LMNA P02545 1/20 0.47
ESR1 P03372 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADRA2A P08913 1/20 0.47
CYP2C9 P11712 1/20 0.47
PDE4A P27815 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRK1 P41145 1/20 0.47
STAT6 P42226 1/20 0.47
HIF1A Q16665 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
SLC10A1 Q14973 1/20 0.45
NPC1 O15118 4/20 0.42
PKM P14618 4/20 0.42
RAB9A P51151 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515754 0.82 SLC6A2 (0.57) KDM4ETSHRSLC6A3ABCB11LMNA
SCHEMBL7377129 0.81 ATM (0.42) KDM4ELMNACYP3A4CYP2C9NPC1
SCHEMBL6176982 0.80 FFAR1 (0.44) KDM4ESLC6A3LMNACYP3A4HIF1A
SCHEMBL20681679 0.79 RAB9A (0.45) AHRKDM4ETSHRLMNANPC1
SCHEMBL1515694 0.79 ACP3 (0.56) LMNACYP3A4CYP2C9NPC1RAB9A
SCHEMBL4775938 0.78 ALDH1A1 (0.52) KDM4ETSHRCYP3A4PKMRAB9A
SCHEMBL7506748 0.78 GRM5 (0.42) KDM4ETSHRCYP3A4NPC1RAB9A
SCHEMBL7097655 0.77 NFE2L2 (0.44) KDM4ETSHRLMNACYP3A4MAPT
SCHEMBL23610031 0.76 SLC10A1 (0.54) AHRKDM4ETSHRSLC6A3ABCB11
SCHEMBL11722266 0.76 AHR (0.54) AHRKDM4ETSHRSLC6A3ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 AHR 4671/4885KDM4E 4034/4885TSHR 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.